Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Adenocarcinoma in Situ
12%
Age Groups
5%
Arm
52%
Attributable Risk
6%
Biopsy Technique
13%
Cancer
10%
Cancer Epidemiology
12%
Cancer Incidence
7%
Cancer Registry
9%
Carcinogenesis
14%
Cervical Cancer
100%
Cervical Cancer Screening
57%
Cervical Intraepithelial Neoplasia
55%
Cervical Screening
22%
Cohort Analysis
12%
Colposcopy
44%
Cytotechnology
93%
Diseases
11%
DNA Screening
19%
Dysplasia
6%
False Negative Result
25%
Health Care Cost
20%
Human Papillomavirus Type 16
5%
Impedance Spectroscopy
12%
Intraepithelial Neoplasia
26%
Krukenberg Tumor
12%
Local Excision
12%
Malignant Neoplasm
23%
Mass Screening
12%
Ovarian Cancer
12%
Papillomavirus Infection
12%
Patient Referral
26%
Precancerous Condition
15%
Prevalence
16%
Prospective Cohort Study
25%
Prospective Study
6%
Public Health
12%
Quality of Life
12%
Reproducibility
16%
Screening Program
7%
Screening Test
22%
Triage
33%
Wart Virus
71%
Keyphrases
Adjunction
12%
Alternative Technology
12%
Attendance Rate
6%
Carcinoma in Situ
12%
Cervical Cancer
33%
Cervical Cancer Screening
40%
Cervical Intraepithelial
12%
Cervical Intraepithelial Neoplasia
23%
Cervical Intraepithelial Neoplasia Grade 3
9%
Clinical Significance
12%
Colposcopy
31%
Conventional Cytology
7%
Cytology Triage
22%
Detection Rate
13%
DNA Testing
12%
Dysplasia
6%
Electrical Impedance Spectroscopy
12%
European Federation
12%
Evaluation Trial
12%
Finland
30%
High-grade Squamous Intraepithelial Lesion
6%
High-risk Human Papillomavirus (HR-HPV)
12%
High-risk Women
12%
HPV16
12%
Human Papillomavirus DNA
12%
Human Papillomavirus Genotyping
12%
Human Papillomavirus Testing
9%
Human Papillomavirus Types
8%
Intraepithelial Adenocarcinoma
12%
Intraepithelial Neoplasia
12%
Invasive Cervical Cancer
9%
LLETZ
12%
Local Excision
12%
Normal Cytology
12%
Organized Screening Program
33%
Overtreatment
12%
Papanicolaou
6%
Population-based
6%
Prospective Cohort Study
25%
Public Health
12%
Quality Indicators
12%
Random Design
8%
Randomized Evaluation
12%
Regional Screening
12%
Routine Screening
12%
Screen-detected
7%
Screening Program
20%
Screening Test
7%
Severe Dysplasia
6%
Technological Alternatives
8%